What was the purpose of the Genvor (GNVR) CEO’s 250,000-share award?

The 250,000-share award to Genvor’s CEO compensates him for converting $125,000 of payables owed by the company. It forms part of a restructured compensation package approved by the board of directors as of December 20, 2024.

Genvor CEO granted 250,000 shares for $125K debt

Genvor Inc. reported that Chief Executive Officer Chad Lee Pawlak Sr. received a grant of 250,000 shares of common stock at $0.50 per share.

Filing Impact

(High)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Genvor Inc. reported that Chief Executive Officer Chad Lee Pawlak Sr. received a grant of 250,000 shares of common stock at $0.50 per share. According to the disclosure, this stock award compensates Mr. Pawlak for converting $125,000 of outstanding payables owed to him by the company under a restructured compensation package approved by the board as of December 20, 2024. Following this grant, he directly holds 7,000,000 shares of Genvor common stock.

Insider Trade Summary

Grant/Award: 250,000 shares

Grant/Award 1 txn

Insider Pawlak Chad Lee Sr.

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	250,000	$0.50	$125K

Holdings After Transaction: Common Stock — 7,000,000 shares (Direct)

Footnotes (1)

F1. Compensation award for Mr. Pawlak's conversion of $125,000 in outstanding payables owed by the Company, pursuant to restructured compensation package approved by the Company's Board of Directors as of December 20, 2024.

Key Figures

Stock grant size: 250,000 shares Grant valuation per share: $0.50 per share Converted payables: $125,000 +1 more

4 metrics

Stock grant size 250,000 shares Common stock award to CEO on April 15, 2026

Grant valuation per share $0.50 per share Value used for CEO compensation share award

Converted payables $125,000 Outstanding payables converted into equity compensation

Post-transaction holdings 7,000,000 shares CEO’s direct Genvor common stock after the grant

Key Terms

grant/award acquisition, restructured compensation package, outstanding payables, Chief Executive Officer

4 terms

grant/award acquisition financial

"transaction_action": "grant/award acquisition""

restructured compensation package financial

"pursuant to restructured compensation package approved by the Company's Board"

outstanding payables financial

"conversion of $125,000 in outstanding payables owed by the Company"

Chief Executive Officer financial

"officer_title": "Chief Executive Officer""

A chief executive officer (CEO) is the top leader of a company, responsible for making major decisions, setting goals, and guiding the organization’s overall direction. Think of the CEO as the captain of a ship, steering it toward success. Investors pay close attention to the CEO because their leadership and strategy can significantly influence the company's performance and future growth.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Genvor (GNVR) disclose for Chad Lee Pawlak Sr.?

Genvor disclosed that CEO Chad Lee Pawlak Sr. received a grant of 250,000 common shares. The award compensates him for converting outstanding payables into equity under a restructured compensation package approved by the board on December 20, 2024.

At what price was the Genvor (GNVR) stock grant to the CEO valued?

The 250,000-share stock grant to Genvor’s CEO was valued at $0.50 per share. This valuation reflects the conversion of $125,000 in outstanding payables into equity under his revised compensation arrangement.

How many Genvor (GNVR) shares does the CEO hold after this Form 4 transaction?

After the reported transaction, Genvor’s CEO directly holds 7,000,000 common shares. This figure includes the 250,000-share award received in exchange for converting $125,000 of payables as part of his restructured compensation package.

Is the Genvor (GNVR) CEO’s Form 4 transaction an open-market purchase or a grant?

The Form 4 shows a grant or award acquisition, not an open-market purchase. The CEO received 250,000 shares as compensation for converting $125,000 in outstanding payables under a board-approved restructured compensation package.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/16/2026 - 10:57 AM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pawlak Chad Lee Sr.

(Last)

(First)

(Middle)

1550 W HORIZON RIDGE PKWY

STE R #3040

(Street)

HENDERSON

NEVADA

89012

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Genvor Inc [ GNVR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/15/2026		A		250,000	A	$0.5⁽¹⁾	7,000,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Compensation award for Mr. Pawlak's conversion of $125,000 in outstanding payables owed by the Company, pursuant to restructured compensation package approved by the Company's Board of Directors as of December 20, 2024.

	/s/ Chad Pawlak	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR